The slip
PARKINSON RECEIPTno. 13121
28 Oct 2026, 14:53 UTColigodendrocytes, braak
predictionSEMA4D in oligodendrocytes tracks Braak Lewy-body stage
registered773ecf9a4fbb8767
discovery-0.17 p=0.654 n=9
replication-0.41 p=0.273 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.17, p 0.654)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT22141ce92181dab8cfeb9696…
follows e69d34deb1fb…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 13121: SEMA4D in oligodendrocytes, braak
- power
- full sample -0.26 (p 0.298, n 18), 95% CI -0.65 to +0.24. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.29 (p 0.239, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.34 (p 0.170, n 18). could be the mix.
- skeptic
- leave-one-out range -0.41 to -0.15, sign flips 0; without severely affected donors -0.26 (p 0.298, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SEMA4D in oligodendrocytes.
case closed: nothing better to follow up.